This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: High-dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next?, Journal of Cancer Research and Clinical Oncology, April 2014, Springer Science + Business Media,
DOI: 10.1007/s00432-014-1670-y.
You can read the full text:
The following have contributed to this page
